(Press-News.org) Effective September 26, 2023, NRG Oncology-RTOG 1308, a phase III randomized trial comparing overall survival after photon versus proton chemoradiotherapy for patients with inoperable stage II-IIIB non-small cell lung cancer (NSCLC) has met its accrual target. The trial, one of several NRG Oncology ongoing clinical trials across various malignancies within the National Clinical Trials Network (NCTN) that compare photon versus proton radiation therapy techniques, is the first phase III head-to-head comparison of these radiation methods to meet accrual.
After stratifying patients by stage, histology, concurrent chemotherapy doublet type, and planned use of immunotherapy, the trial randomized patients with clinical American Joint Committee on Cancer (AJCC) 7th edition inoperable stage II, IIIA, or IIIB disease to either 70 Gy (relative biological effectiveness, RBE) of photon or proton radiation therapy [2 Gy (RBE) once daily] plus standard-of-care platinum-based doublet chemotherapy. Following chemoradiotherapy, both groups receive standard-of-care consolidation systemic treatment. Of a total of 330 patients enrolled (328 from participating institutions in the United States and 2 from Switzerland), 158 were randomized to the photon group and 172 to the proton group. The study opened to accrual in February 2014 and accrued its first patient in April 2014.
The study is designed to assess whether proton therapy will improve the rate of overall survival and decrease the rate of treatment-related cardiac toxicity compared to standard photon therapy for patients with inoperable locally advanced NSCLC. The study’s co-primary objectives compare overall survival and treatment-related cardiac toxicity/lymphocyte reduction across the treatment groups. Secondary objectives include 2-year progression-free survival; development of grade 3 or higher adverse events not related to cardiac and lymphocyte toxicity; quality of life; cost-effectiveness; pulmonary function changes; and an exploration of clinically relevant technological parameters to ensure quality and effectiveness throughout radiation therapy processes, including imaging, simulation, patient immobilization, target and critical structure definition, treatment planning, image guidance and delivery.
“The completion of accrual to the NRG Oncology-RTOG 1308 study brings the oncology community one step closer to a definitive comparison between photon and proton radiation therapy techniques in patients with inoperable locally advanced NSCLC,” stated Zhongxing Liao, MD, of the University of Texas MD Anderson Cancer Center and lead investigator of the study. “My co-investigators and I look forward to the maturation of results so that we can continue to refine evidence-based treatment decisions on radiation approach in this patient population, and we are immensely grateful to the staff and patients who participated in the trial to lead us to this point.”
A read-out of the primary endpoint results is anticipated to be complete in December 2026, with secondary endpoint analyses expected the year afterward.
This project was supported by the NRG Oncology Operations grant U10CA180868 and the NRG Oncology SDMC grant U10CA180822 from the National Cancer Institute (NCI), part of the National Institutes of Health and conducted by the NCI National Clinical Trials Network.
Citation
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC. ClinicalTrials.gov Identifier: NCT01993810
About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG) programs. The research network seeks to conduct clinical trials with emphasis on gender-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology’s extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI’s National Clinical Trials Network.
www.nrgoncology.org
END
NRG Oncology-RTOG 1308 accrual completion: First phase III NCTN clinical trial comparing photon versus proton therapy to meet accrual target
2023-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Carbon capture method plucks CO2 straight from the air
2023-10-03
Even as the world slowly begins to decarbonize industrial processes, achieving lower concentrations of atmospheric carbon requires technologies that remove existing carbon dioxide from the atmosphere — rather than just prevent the creation of it.
Typical carbon capture catches CO2 directly from the source of a carbon-intensive process. Ambient carbon capture, or “direct air capture” (DAC) on the other hand, can take carbon out of typical environmental conditions and serves as one weapon in the battle against climate change, particularly as reliance ...
Dr. Tanya Stoyanova receives Department of Defense award to find new lung cancer treatments
2023-10-03
Dr. Tanya Stoyanova, associate professor of molecular and medical pharmacology and urology at the David Geffen School of Medicine at UCLA, was awarded a $350,000 Idea Development Award from the Department of Defense.
The award will help Stoyanova, a member of the UCLA Jonsson Comprehensive Cancer Center, to identify new cancer detection and treatment strategies for small cell lung cancer, a highly aggressive form of the disease that accounts for approximately 15% of lung cancers. Known for spreading quickly, most people diagnosed with the disease face low chances of survival beyond five years.
The award ...
Carol L. Silva elected fellow of the National Academy of Public Administration
2023-10-03
Carol L. Silva, the Edith Kinney Gaylord Presidential Professor of Political Science in the Dodge Family College of Arts and Sciences and Senior Associate Vice President for Research and Partnerships at the University of Oklahoma, has been elected a 2023 fellow of the National Academy of Public Administration.
“Carol is an experienced, dynamic leader with an extensive record of excellence in research and building successful multidisciplinary programs and convergent teams focused on grand challenge problems at the intersection of public policy and technology. We congratulate her on this election to the NAPA and look forward to the impact she will make among these national thought ...
Independent physician practices can keep up with larger consolidated practices in a pandemic
2023-10-03
Large health systems are acquiring smaller physician practices at what some consider an alarming rate, leaving fewer independent practices. When the COVID-19 pandemic occurred, it was unclear whether the independent practices would be able to “keep up” (maintain the same level of patient care) with larger practices, which have more resources, and if care for patients with chronic conditions might be disrupted by the pandemic.
A new study from Associate Dean of Research Alison Cuellar found that independent practices experienced a smaller drop in patient volume than ...
Join GSA in Tampa for the Nation’s Premier Aging Conference!
2023-10-03
The Gerontological Society of America (GSA) invites all journalists to attend its 2023 Annual Scientific Meeting — the country’s largest interdisciplinary conference in the field of aging — from November 8 to 12 in Tampa, Florida. Qualified media representatives intending to cover the meeting may register free of charge.
More than 3,000 professionals are expected to attend the five-day gathering at the Tampa Convention Center. The theme for 2023 is “Building Bridges > Catalyzing Research > Empowering All Ages,” and the program schedule contains ...
Female animals may learn mate preferences based on what sets other females’ choices apart from the crowd
2023-10-03
Females may infer what makes a male attractive by observing the choices of more experienced females, and the context of those choices matters, according to a mathematical model publishing October 3rd in the open access journal PLOS Biology. Rather than simply copying their peers, females might learn to prefer rare traits that set successful males apart from others, Emily DuVal at Florida State University, US, and colleagues report.
Sexual selection — where traits become more common because of their attractiveness to the opposite sex — can produce strange and elaborate characteristics, such as huge antlers, bright plumage, and ...
Despite increasing rates of tuberculosis in prisons across the globe, current WHO TB prevention guidelines fail to reach incarcerated populations
2023-10-03
Despite increasing rates of tuberculosis in prisons across the globe, current WHO TB prevention guidelines fail to reach incarcerated populations. Programs should instead prioritize them, argue a group of researchers from Stanford, Harvard, UCL and a range of other global institutions.
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004288
Article Title: Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment
Author Countries: United States
Funding: ...
Computer model predicts who needs lung cancer screening
2023-10-03
A machine learning model equipped with only data on people’s age, smoking duration and the number of cigarettes smoked per day can predict lung cancer risk and identify who needs lung cancer screening, according to a new study publishing October 3rd in the open access journal PLOS Medicine by Thomas Callender of University College London, UK, and colleagues.
Lung cancer is the most common cause of cancer death worldwide, with poor survival in the absence of early detection. Screening for lung cancer among those at highest risk could reduce ...
Rural counties showing steeper decline in health measures compared to urban counties in 2015 versus 2019—though all areas showed declines in health measures over time
2023-10-03
Residents of rural counties have overall worse health outcomes than their urban counterparts. A study published in PLOS Global Public Health by William Weeks at Microsoft Corporation, Redmond, Washington, United States and colleagues introduces a Health Equity Dashboard for policy makers to visualize health disparities in specific locations, and to examine the relationship between health-related measures and socio-demographic characteristics.
Despite overall decreasing mortality rates prior to 2020, health disparities between rural and urban areas in the United States have increased. To better understand inequities in health-related measures between rural and non-rural populations, ...
Interconnected factors increase household food insecurity in Brazil
2023-10-03
Food insecurity is four times higher in Brazilian households headed by single women of colour than those headed by married white men, according to research published in the open access journal PLOS Global Public Health. Gender inequities, skin colour and children in the home increase the risk of food insecurity and the authors argue that policy makers need to consider intersectionality in programmes to reduce it.
In 2021 there were 2.37 billion people suffering from food insecurity, with prevalence higher among women than men. The gender gap has increased in recent years, especially in the economic crisis triggered by the COVID-19 pandemic. ...